Targeted clinical research to address select viral infections

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201600014C
Awardee
Awarding agency
Obligated
$5,835,169

Award facts

Opportunity
Contract value 100% obligated
$5,835,169.39 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00013 $0
Funding Only Action P00012 -$68,559
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Funding Only Action P00009 -$185,436
Other Administrative Action P00008 $0
Other Administrative Action P00007 · To complete enrollment and closeout for the multicenter prospective observational study to investigate adenovirus infection and other important infections in… $0
Exercise an Option P00006 · To exercise option three - protocol closeout. $691,657
Other Administrative Action P00005 · Option one. 04/04/2017 - 04/03/2020. Targeted clinical research to address select viral infections. $0
Exercise an Option 4 · Option two. 08/22/2018 - 08/21/2021. Targeted clinical research to address select viral infections. $2,360,109
Change Order 2 $0
Exercise an Option 1 $1,903,837
Other Administrative Action 3 $0
Original award $1,133,561
Show all 14

About this award

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) for "Targeted Clinical Research to Address Select Viral Infections." The $5,835,169.39 definitive contract is for a 7-year period ending in May 2024. It does not have a set-aside designation.

Under this contract, CHOP leads a multi-site observational study on human adenovirus infection and disease in pediatric stem cell transplant recipients. CHOP coordinates with several subcontractors, including Lovelace Biomedical Research Institute, Childrens Hospital Medical Center, and the University of Pittsburgh, to enroll patients, collect and analyze samples, and maintain the study database. NIAID's mission includes conducting and supporting research to understand, treat, and prevent infectious diseases, which aligns with the goals of this clinical research project.

Quick answers

Who was awarded contract HHSN272201600014C?

HHSN272201600014C was awarded to The Children's Hospital Of Philadelphia by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2016.

How much is contract HHSN272201600014C worth?

The government has obligated $5,835,169 on HHSN272201600014C.

Was contract HHSN272201600014C competed?

The extent of competition for HHSN272201600014C was full and open competition. The government received 13 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award